UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 14,
VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more VYNE Therapeutics Charts.
VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more VYNE Therapeutics Charts.

Vyne Therapeutics Inc. News

Form S-3 - Registration statement under Securities Act of 1933
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Saturday 3 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

More Vyne Therapeutics Inc. News Articles